23 May 2013
Keywords: avant, demands, berlin, stock, exchange, de-listing, firm
Article | 02 August 2004
US firm AVANT Immunotherapeutics is the latest to demand an immediatede-listing from the Berlin-Bremen, Germany, Stock Exchange in an attempt
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
2 August 2004
22 May 2013
© 2013 thepharmaletter.com